Concepedia

Publication | Open Access

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

DOIFull Paper Access

212

Citations

8

References

1996

Year

Robert Löfberg, Paul Rutgeerts, H Malchow, C. B. H. W. Lamers, Åke Danielsson, Gunnar Olaison, D P Jewell, Ole Østergaard Thomsen, H. Lorenz‐Meyer, H. Goebell,
Gut

Abstract

6 mg budesonide once daily is significantly more efficacious than placebo in prolonging time to relapse in CD, and causes only minor systemic side effects.

References

YearCitations

Page 1